Sacroiliac Joint Injection in Manhattan and NYC

A sacroiliac joint injection is a targeted injection used to evaluate or temporarily reduce pain from the sacroiliac joint, also called the SI joint. The injection may include local anesthetic, corticosteroid, or another medication depending on the treatment goal. It may be diagnostic, therapeutic, or both. At MPM, an SI joint injection is considered only after evaluating whether the SI joint is likely contributing to lower back, buttock, hip, groin, or pelvic-region pain.

The SI joint connects the sacrum at the base of the spine to the ilium of the pelvis. It helps transfer load between the spine and lower body. Because it sits between the lower back, pelvis, and hips, SI joint pain can overlap with spine pain, hip pain, pelvic pain, or sciatica-like symptoms. MPM evaluates the SI joint in the context of the patient’s full musculoskeletal, inflammatory, and pelvic pain pattern.

SI joint pain may feel like lower back pain, buttock pain, hip pain, groin pain, pelvic-region pain, or pain that travels into the thigh. Some patients feel worse with standing, walking, stairs, rolling in bed, prolonged sitting, or transitioning from sitting to standing. Similar symptoms can occur with disc herniation, sciatica, facet pain, hip pathology, cluneal neuralgia, pelvic floor dysfunction, or inflammatory arthritis, so careful evaluation is important.

An SI joint injection may help selected patients when the SI joint is a meaningful pain generator. It may provide temporary relief and can help clarify whether symptoms are truly coming from the SI joint. It does not cure all lower back, buttock, hip, or pelvic pain. MPM evaluates whether symptoms may instead be related to lumbar spine disease, hip pathology, pelvic floor dysfunction, nerve pain, inflammation, or hypermobility-related instability.

An SI joint injection can be diagnostic, therapeutic, or both. A diagnostic injection uses numbing medication to help determine whether the SI joint is contributing to pain. A therapeutic injection may include corticosteroid to reduce inflammation and pain for a period of time. Relief may be temporary, but the pattern of response can guide next steps, including rehabilitation, rheumatology care, regenerative medicine, spine procedures, or SI joint fixation and fusion evaluation.

SI joint pain often starts around the lower back, buttock, or pelvic region and may refer into the hip, groin, or thigh. Sciatica usually involves irritation of a nerve root, often causing pain that travels down the leg with numbness, tingling, or weakness. The two can overlap or mimic each other. MPM evaluates the spine, SI joint, hips, nerves, and pelvic mechanics before deciding whether an SI joint injection is appropriate.

Facet pain, disc pain, and SI joint pain can all cause lower back or buttock symptoms. Facet pain often comes from small spinal joints, while disc-related pain may involve disc injury, inflammation, or nerve root irritation. SI joint pain comes from the joint between the sacrum and pelvis. MPM uses history, exam findings, provocative testing, imaging review, and sometimes diagnostic injections to help distinguish these pain generators.

SI joint injections may help selected patients with sacroiliitis when inflammation in or around the SI joint is contributing to pain. Inflammatory sacroiliitis may be related to autoimmune or rheumatologic conditions such as seronegative spondyloarthropathy or psoriatic arthritis. An injection may reduce local inflammation temporarily, but it does not replace rheumatology evaluation, disease-directed medication, physical therapy, or broader inflammatory pain management when needed.

SI joint injections may be considered for selected autoimmune or inflammatory SI joint pain when local inflammation appears to be contributing to symptoms. However, autoimmune-related pain often requires coordinated care, which may include rheumatology evaluation, lab review, imaging, medication management, DMARDs, biologics, physical therapy, or other treatment. MPM evaluates whether the SI joint is the correct target and whether inflammation, mechanics, or both are involved.

SI joint injections may help selected patients with hypermobility or EDS-related SI region pain when the SI joint is contributing to symptoms. However, injections do not cure hypermobility, EDS, or joint instability. MPM evaluates joint mechanics, pelvic alignment, muscle compensation, ligamentous laxity, spine and hip contributors, and functional goals before deciding whether injection, bracing, physical therapy, prolotherapy, PRP, or another pathway may be appropriate.

Image guidance is commonly used for SI joint injections when clinically appropriate because the SI joint can be difficult to access accurately by landmarks alone. Depending on the clinical setting, guidance may include fluoroscopy, CT, or ultrasound in selected circumstances. MPM determines the appropriate approach based on anatomy, diagnosis, safety factors, and treatment goals. Image guidance supports accuracy but does not guarantee relief.

Relief varies by patient, diagnosis, medication used, inflammation level, joint mechanics, and whether other pain generators are present. Some patients feel short-term relief from numbing medication, while steroid-related improvement may take longer and may last days, weeks, or longer in selected cases. Some patients do not respond. MPM reviews the timing, location, and duration of relief to guide next steps.

Temporary relief can still be useful because it may suggest that the SI joint is contributing to pain. Depending on the response, MPM may consider physical therapy, pelvic floor therapy, rheumatology coordination, steroid injection planning, PRP, prolotherapy, regenerative medicine, spine treatment, cluneal nerve evaluation, or SI joint fixation and fusion evaluation when appropriate. If relief is limited or does not match the expected pattern, the diagnosis may need to be refined.

An SI joint injection often refers to local anesthetic or corticosteroid injection used for diagnosis or inflammation-related pain relief. PRP and prolotherapy are regenerative medicine approaches that may be considered for selected musculoskeletal or instability-related pain patterns. These treatments have different goals, evidence considerations, recovery expectations, and risks. MPM determines which approach, if any, best fits the patient’s diagnosis, anatomy, prior response, and care goals.

SI joint fixation or fusion may be considered only for selected patients with persistent SI joint-mediated pain after careful diagnosis and when less invasive treatments have not provided enough benefit. An SI joint injection may sometimes help confirm whether the SI joint is a meaningful pain generator before more advanced options are considered. MPM evaluates the full clinical picture, including spine, hip, pelvic, inflammatory, and hypermobility-related factors, before referral or escalation.

Risks may include pain flare, bruising, bleeding, infection, allergic reaction, temporary numbness or weakness, vasovagal reaction, steroid-related side effects, elevated blood sugar, tissue effects with repeated steroid exposure, incomplete relief, temporary relief only, or no relief. MPM reviews risks before treatment. Fever, spreading redness, severe swelling, new weakness, new numbness, bowel or bladder dysfunction, saddle anesthesia, severe trauma-related pain, chest pain, shortness of breath, or rapidly worsening symptoms require urgent evaluation.